Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bela Merkely

Showing results (191-200 of 296) with videos related to

Pageof 30
Sort By:
JACC. Heart Failure|June 15, 2024
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline CharacteristicsMikhail N Kosiborod, David Cherney, Kim Connelly, et al.
Circulation|November 25, 2016
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)C Michael Gibson, Serge Korjian, Pierluigi Tricoci, et al.
Heart Rhythm|August 6, 2025
PPG-based smartphone application vs usual care for atrial fibrillation screening: A European multicenter randomized trialJakob Johannes Reichl, Khaled Abdel Hamid, Thilo Burkard, et al.
Eclinicalmedicine|February 8, 2021
Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort studyMichael Dommasch, Alexander Steger, Petra Barthel, et al.
Nature Medicine|October 6, 2025
Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fractionMuthiah Vaduganathan, Brian L Claggett, Safia Chatur, et al.
Lancet (London, England)|February 27, 2015
Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)Jeff S Healey, Stefan H Hohnloser, Michael Glikson, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty)Christian Spaulding, Emmanuel Teiger, Philippe Commeau, et al.
Circulation. Heart Failure|March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF AnalysisLuis E Rohde, Brian L Claggett, Emil Wolsk, et al.
The New England Journal of Medicine|August 29, 2017
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial FibrillationChristopher P Cannon, Deepak L Bhatt, Jonas Oldgren, et al.
JAMA Cardiology|July 27, 2018
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical TrialStephen J Nicholls, Jordan Andrews, John J P Kastelein, et al.
Pageof 30

Showing results (191-200 of 296) with videos related to

Sort By:
Pageof 30
JACC. Heart Failure|June 15, 2024
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline CharacteristicsMikhail N Kosiborod, David Cherney, Kim Connelly, et al.
Circulation|November 25, 2016
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)C Michael Gibson, Serge Korjian, Pierluigi Tricoci, et al.
Heart Rhythm|August 6, 2025
PPG-based smartphone application vs usual care for atrial fibrillation screening: A European multicenter randomized trialJakob Johannes Reichl, Khaled Abdel Hamid, Thilo Burkard, et al.
Eclinicalmedicine|February 8, 2021
Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort studyMichael Dommasch, Alexander Steger, Petra Barthel, et al.
Nature Medicine|October 6, 2025
Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fractionMuthiah Vaduganathan, Brian L Claggett, Safia Chatur, et al.
Lancet (London, England)|February 27, 2015
Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)Jeff S Healey, Stefan H Hohnloser, Michael Glikson, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty)Christian Spaulding, Emmanuel Teiger, Philippe Commeau, et al.
Circulation. Heart Failure|March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF AnalysisLuis E Rohde, Brian L Claggett, Emil Wolsk, et al.
The New England Journal of Medicine|August 29, 2017
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial FibrillationChristopher P Cannon, Deepak L Bhatt, Jonas Oldgren, et al.
JAMA Cardiology|July 27, 2018
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical TrialStephen J Nicholls, Jordan Andrews, John J P Kastelein, et al.
Pageof 30